Drawing for HOPE PLATFORM

USPTO serial 90380008

HOPE PLATFORM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NOBLE, ANNIE MELISSA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HOPE PLATFORM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Kreider Gaunt

Karen Kreider Gaunt DINSMORE & SHOHL LLP255 E. FIFTH ST., SUITE 1900CINCINNATI, OH 45202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware for scientific and medical purposes; Computer hardware and computer peripheral devices for use in cancer treatment for medical purposes; Downloadable medical software to target therapeutic treatments for patient specific cancers; Downloadable computer software for medical diagnostic imaging for use in cancer treatment; Downloadable and recorded software in the medical field for cancer treatment by integration and interpretation of molecular raw data into actionable clinical actions; Computer robotics-supported workstations in the nature of laboratory equipment and instruments, comprised of integrated multi-axis robots, video cameras and integrated software for visualization of workstation operations, sensors and integrated software for environmental control of the workstation, dispensing valves for dispensing preset portions of fluids, solid granules and powder, three-dimensional (3D) printers and cartridges for containing printing material, all sold as a unitACTIVE—
042Software as a Service (SaaS) services featuring medical software for use in cancer treatment; Platform as a service (PAAS) consisting of computer software platforms and applications featuring machine-learning focused data aggregation and inferencing, and image segmentation, all within the field of biomedical applications; Medical and scientific research services in the field of cancer treatment; Providing laboratory research services in the field of cancer treatment; Providing scientific research information in the field of cancer treatment; Computer programming in the medical field; Computer programming services for medical applications; Design and development of computer software for use in the field of medical technology; Development of information system software for medical purposes; Design, engineering, research, development and testing of computer software for medical applications; Scientific research; Medical research; Biological research; Research and development in the biotechnology field; Medical laboratory servicesACTIVE—
044Medical services; Cancer treatment services; Medical testing in the field of cancer; Medical testing in the field of oncology; Medical diagnostic testing, monitoring, or reporting services; Medical analysis or advisory services in the field of cancer; Medical analysis or advisory services in the field of oncology; Medical analysis or advisory services for medical treatment; Qualitative image analysis in the field of digital pathology for medical purposes; Quantitative image analysis in the field of digital pathology for medical purposes; Providing non-research related medical information via the internet; Medical analysis services for the diagnosis of cancer by reviewing pathological samples on slidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 20, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 7, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 6, 2023EX3GSOU EXTENSION 3 GRANTED—
Nov 6, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 20, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 20, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 20, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 20, 2023PETGPETITION TO REVIVE-GRANTED—
Oct 20, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Oct 19, 2023EXT3SOU EXTENSION 3 FILED—
Apr 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 12, 2023EX2GSOU EXTENSION 2 GRANTED—
Apr 12, 2023EXT2SOU EXTENSION 2 FILED—
Apr 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 11, 2022EX1GSOU EXTENSION 1 GRANTED—
Oct 11, 2022EXT1SOU EXTENSION 1 FILED—
Oct 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 19, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 22, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 22, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 2, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 19, 2022ALIEASSIGNED TO LIE—
Jan 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 9, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2021DOCKASSIGNED TO EXAMINER—
Feb 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance